These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11536205)

  • 1. Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions.
    Law D; Krill SL; Schmitt EA; Fort JJ; Qiu Y; Wang W; Porter WR
    J Pharm Sci; 2001 Aug; 90(8):1015-25. PubMed ID: 11536205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluations.
    Law D; Schmitt EA; Marsh KC; Everitt EA; Wang W; Fort JJ; Krill SL; Qiu Y
    J Pharm Sci; 2004 Mar; 93(3):563-70. PubMed ID: 14762895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H; Fussnegger B; Bodmeier R
    Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions.
    Liu C; Desai KG
    Pharm Dev Technol; 2005; 10(4):467-77. PubMed ID: 16370176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
    Purohit HS; Taylor LS
    Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enabling thermal processing of ritonavir-polyvinyl alcohol amorphous solid dispersions by KinetiSol® Dispersing.
    LaFountaine JS; Jermain SV; Prasad LK; Brough C; Miller DA; Lubda D; McGinity JW; Williams RO
    Eur J Pharm Biopharm; 2016 Apr; 101():72-81. PubMed ID: 26861929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of dissolution of ethopropazine using solid dispersions prepared with phospholipid and/or polyethylene glycol.
    Prabhu S; Brocks DR; Betageri GV
    Drug Dev Ind Pharm; 2001 May; 27(5):413-8. PubMed ID: 11448048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallization Kinetics of Indomethacin/Polyethylene Glycol Dispersions Containing High Drug Loadings.
    Duong TV; Van Humbeeck J; Van den Mooter G
    Mol Pharm; 2015 Jul; 12(7):2493-504. PubMed ID: 26056715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Surfactants on Release Performance of Amorphous Solid Dispersions of Ritonavir and Copovidone.
    Indulkar AS; Lou X; Zhang GGZ; Taylor LS
    Pharm Res; 2022 Feb; 39(2):381-397. PubMed ID: 35169959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of the dissolution profile of allopurinol by a solid dispersion technique.
    Samy AM; Marzouk MA; Ammar AA; Ahmed MK
    Drug Discov Ther; 2010 Apr; 4(2):77-84. PubMed ID: 22491164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the aqueous solubility and permeability of a poorly water soluble drug ritonavir via lyophilized milk-based solid dispersions.
    Dhore PW; Dave VS; Saoji SD; Bobde YS; Mack C; Raut NA
    Pharm Dev Technol; 2017 Feb; 22(1):90-102. PubMed ID: 27291246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions.
    Dengale SJ; Ranjan OP; Hussen SS; Krishna BS; Musmade PB; Gautham Shenoy G; Bhat K
    Eur J Pharm Sci; 2014 Oct; 62():57-64. PubMed ID: 24878386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and physicochemical characterization of saquinavir mesylate solid dispersions using Gelucire 44/14 or PEG 4000 as carrier.
    Caon T; Konig RA; da Cruz AC; Cardoso SG; Campos CE; Cuffini SL; Koester LS; Simões CM
    Arch Pharm Res; 2013 Sep; 36(9):1113-25. PubMed ID: 23700292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
    Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
    Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
    Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical characterization and dissolution study of solid dispersions of diacerein with polyethylene glycol 6000.
    Aggarwal AK; Singh S
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1181-91. PubMed ID: 21449824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions.
    Verheyen S; Blaton N; Kinget R; Van den Mooter G
    Int J Pharm; 2002 Dec; 249(1-2):45-58. PubMed ID: 12433433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissolution rate of furosemide from polyethylene glycol solid dispersions.
    Ozdemir N; Ordu S
    Farmaco; 1997 Oct; 52(10):625-9. PubMed ID: 9507675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems.
    Thenmozhi K; Yoo YJ
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1501-1509. PubMed ID: 28425323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.